Companion Society Meetings

Arthur Purdy Stout Society of Surgical Pathologists

What You See is What You Get: Let the Gross Examination be Your Guide

Sunday, March 18, 2018, 8:30 AM - 12:00 PM

Session Credits:

3 CME and 3 SAMs

Moderators:

Rhonda K. Yantiss, MD, Weill Cornell Medical College, New York, NY
Vania Nose, MD, Massachusetts General Hospital, Boston, MA

Course Description:

Pathologists must perform several functions when assessing resection specimens, including tumor staging in cancer cases, assessment of resection adequacy, and documentation of non-neoplastic disease. In fact, accurate classification of non-neoplastic disease can only be made in light of the findings at gross examination in many cases. Pathologists need to understand the anatomy and lesional findings in complex resection specimens, not only to accurately document extent of disease, but to facilitate judicious submission of an appropriate number of tissue blocks. Systematic pathologic evaluation of cancer resection specimens plays a vital role in determining the patient's prognosis and facilitating decisions regarding use of adjuvant therapy. The upcoming 8th edition of the AJCC Cancer Staging Manual introduces new concepts regarding distinction between gross tumor characteristics and microscopic invasive disease for purposes of cancer staging, and builds upon prior schemes regarding staging of neoadjuvantly treated cancers. This session will focus on incorporating gross findings into overall pathologic assessment of surgical resection specimens. Attention will be given to interpretation of gross findings of complex surgical specimens for non-neoplastic and neoplastic indications, tumor staging issues introduced by the 8th edition of the AJCC Cancer Staging Manual, and effects of neoadjuvant therapies on gross and microscopic findings.

Learning Objectives:

Upon completion of this educational activity, the learner will be able to:

  • Identify and judiciously sample carcinomas in neoadjuvantly treated breast excision specimens
  • Identify landmarks that allow distinction between serosal penetration and extension to the radial margin among colonic adenocarcinomas, including those of the rectum
  • Orient, describe, and sample resection specimens that include the proximal pancreas, ampulla, and duodenum
  • Orient complex head and neck resection specimens and recognize extent of disease for directed sampling
  • Develop a differential diagnosis for grossly cystic pulmonary lesions
  • Recognize lesional tissue in non-neoplastic and neoplastic bone resection specimens

 

8:45 AM The Challenge of Evaluating Post-Neoadjuvant Systemic Therapy Breast Specimens
Stuart Schnitt, MD, Brigham and Womens' Hospital, Boston, MA
9:10 AM The Importance of Gross Examination in Staging Colorectal Carcinoma
Wendy Frankel, MD, Ohio State University, Columbus, OH
9:35 AM A Practical Approach to Dissecting Pancreaticobiliary Specimens Improves Diagnosis and Staging
N. Volkan Adsay, MD, Medical College of Wisconsin, Milwaukee, WI
10:00 AM Break
10:40 AM The Effects of Sampling on Accurate Staging of Head and Neck Cancers
Peter Sadow, MD, Massachusetts General Hospital, Boston, MA
11:05 AM The Importance of Gross Examination in Lung Cancer Staging and Diagnosis of Non-neoplastic Diseases
Jeffrey Myers, MD, University of Michigan, Ann Arbor, MI
11:30 AM Putting it All Together: Radiologic and Gross Evaluation of Bone and Joint Diseases
Michael J. Klein, MD, The Hospital for Special Surgery, New York, NY

 

Continuing Medical Education and Maintenance of Certification

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and Arthur Purdy Stout Society of Surgical Pathologists. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this live activity for a maximum of
3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Physicians must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 3 SAM credit hours.

 

Return to 2018 Annual Meeting Companion Society Meetings Page

Meetings

view more